Today it was reported that the VP & Controller of West Pharmaceutical Services, Inc. (WST), Daniel Malone, exercised options to sell 4,458 WST shares at $21.34 a share, for a total transaction value of $548.5K.
Following Daniel Malone’s last WST Sell transaction on June 12, 2018, the stock climbed by 26.0%.
See today’s analyst top recommended stocks >>
Based on West Pharmaceutical Services, Inc.’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $444 million and quarterly net profit of $55.4 million. In comparison, last year the company earned revenue of $416 million and had a net profit of $43.6 million. WST’s market cap is $9.17B and the company has a P/E ratio of 42.72. Currently, West Pharmaceutical Services, Inc. has an average volume of 54.21K.
Daniel Malone’s trades have generated a -8.6% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products.
